Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0029-2025

Drug recall · November 6, 2024

Chlorpheniramine Maleate 4 mg tablets recall

Why: Superpotent Drug: Stability failure for assay at 6 months test time-point.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24

Lots / codes

Lot # 24A27724, Exp 01/31/2027

Quantity
4,901 cases/24 count each case
Company
BLI International, Inc., Deer Park, NY
Distribution
Product was shipped to two private label customers ( OH & MO) as a final packaged product.
Initiated
October 21, 2024 · Voluntary: Firm initiated
Classified
October 30, 2024
Reported
November 6, 2024
Ended
December 5, 2025
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Chlorpheniramine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.